AKYNZEO (Eisai Inc.)
Welcome to the PulseAid listing for the AKYNZEO drug offered from Eisai Inc.. This Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eisai Inc. |
| NON-PROPRIETARY NAME: | Netupitant and Palonosetron |
| SUBSTANCE NAME: | NETUPITANT; PALONOSETRON |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-10-13 |
| END MARKETING DATE: | 2018-05-31 |
AKYNZEO HUMAN PRESCRIPTION DRUG Details:
| Item Description | AKYNZEO from Eisai Inc. |
| LABELER NAME: | Eisai Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2014-10-13 |
| END MARKETING DATE: | 2018-05-31 |
| PRODUCT ID: | 62856-796_bfdbd210-182f-4d0b-8004-e815bab26444 |
| PRODUCT NDC: | 62856-796 |
| APPLICATION NUMBER: | NDA205718 |
Other NETUPITANT; PALONOSETRON Pharmaceutical Manufacturers / Labelers:
